Child Labour in India

The next meeting of GIRT Hamburg on 19th March will deal with the issues of child labour in India. Mr. Helge Adolphsen and his colleagues from the Stiftung Asien-Brücke (a charitable trust founded by the Senate and the Parliament of the Free and Hanseatic City of Hamburg) will inform about projects undertaken by them.

For those interested, we are providing a list of some related publications:

Airbus sees India in need of over 1,040 aircraft worth US$145 billion in next 20 years

Airbus says: „India needs over 1,040 aircraft worth US$145 billion in next 20 years“ and sees demand for larger eco-efficient aircraft

15 March 2012 Press Release

According to Airbus’ latest market forecast, Indian carriers will require 1,043 new passenger (1,020) and freighter (23) aircraft valued at US$145 billion between now and 2030 to satisfy surging annual demand. India’s market for new aircraft makes it the world’s fourth largest in both number of aircraft and value.

Indian annual passenger traffic growth rates of 7.2 per cent are well above the regional Asia Pacific average growth rate of 5.9 per cent and the world average 4.8 per cent.

Of the requirement for 1,020 new passenger aircraft, some 860 will be for growth and 160 to replace the eldest aircraft in the existing fleet of 327. By 2030, this means that India’s passenger fleet will more than triple to some 1,180 aircraft. The new passenger aircraft include 646 single aisles like the A320 and A320neo Family, 308 twin aisles like the A350 XWB and A330, and 66 very large aircraft such as the A380.

Growing urbanization and population concentrations combined with a growing middle class and dynamic economic growth are driving demand and this trend is expected to continue. Despite near term challenges, the Indian economy is forecast to continue expanding, helping India’s growth in domestic air travel to reach even higher growth rates of nearly 10 per cent annually, making it one of the fastest growing aviation markets anywhere in the world.

“By 2030, India’s economy is forecast to be the fourth largest in the world creating exceptional potential for growth in the aviation sector. Through our Indian industrial partnerships we are proud to boast that every A320 today is partly made in India,” said Dr. Kiran Rao, Airbus Executive Vice President, Sales and Marketing, and President of Airbus India. “Our engineering and industrial footprint in India supports over 2,000 highly skilled Indian jobs throughout our supply chain, and this figure is growing.”

Airbus’ partnership with India dates back almost 40 years. Today, half of all A320 forward doors and all flap track beams are produced in India. Established in 2006, the Airbus Engineering Centre India (AECI) in Bangalore employs over 270 highly skilled local engineers working in high end analysis and design on all Airbus products. The centre is expected to grow to 450 over the next three years. Airbus recently established a second pilot training centre in Noida (this one in cooperation with CAE and Interglobe) to complement the existing facility in Bangalore. Combined, they will have the capacity to train up to 5,000 pilots and maintenance engineers per year. Airbus’ market share of new aircraft orders in India is over 70 per cent.

Source: Airbus‘ Press Release, dated: 15.03.2012.

India’s new budget proposes new tax slabs, more expenditure on education

Direct Links:

India orders ‘compulsory license’ for Bayer’s cancer drug

According to one report in the Economic Times (13.03.2012):

The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany’s Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry’s anxiety over the use of the controversial compulsory licensing provision.

The outgoing patent controller of India, PH Kurian, on Monday granted the country’s first compulsory licence to Hyderabad-based Natco Pharma, permitting it to manufacture and market a generic version of Nexavar, a medicine used for treating liver and kidney cancer, in India for just 3% of the patented drug’s price in return for paying 6% royalty on sales to Bayer.

[…] Bayer is expected to legally challenge the decision. “We will evaluate our options to further defend our intellectual property rights in India,” a company spokesman said. […]

Source: “Natco Pharma bags licence to sell Bayer’s cancer drug Nexavar” (Economic Times, 13.03.2012)

Also see: “India patent ruling may open door for cheaper HIV drugs” (Economic Times, 13.03.2012)

Indo-German Trade Continues its Dream Run in 2011

The bilateral trade volume in calendar year 2011 is estimated to have stood at €18.4 billion, up from €15.5 billion in 2010, thereby registering a staggering growth of 18.7%. The growth in bilateral exports and imports outperformed the overall growth in Germany’s trade with the rest of the world. While Germany’s exports to India grew by 17.1% on yearly basis and stood at €10.87 billion, the imports grew by 20.2% reaching €7.5 billion.

Read the complete report titled „Indo-German Trade Continues its Dream Run in 2011: Bilateral business defies financial crisis and economic slowdown„.